Marquette Asset Management, LLC Catalyst Biosciences, Inc. Transaction History

Marquette Asset Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 23, 2021	SELL	$4.93 - $7.15 $32,025 - $46,446	-6,496 Closed	0 $0
Q2 2020 Jul 21, 2020	SELL	$3.76 - $8.01 $20,649 - $43,990	-5,492 Reduced 45.81%	6,496 $38,000
Q1 2020 Apr 08, 2020	BUY	$3.5 - $8.51 $41,958 - $102,017	11,988 New	11,988 $52,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Marquette Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Marquette Asset Management, LLC with notifications on news.